Philips CEO Roy Jakobs expects the subdued demand in China to continue in 2025, as tariffs also cause market uncertainty.

PHG's fourth-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious outlook.

Q4 2024 Earnings Call Transcript February 19, 2025 Koninklijke Philips N.V. misses on earnings expectations. Reported EPS is ...

Philips forecast a double-digit sales decline in China for the first half of 2025 after reporting “significant deterioration” ...

Discover Philips' Q4 2024 earnings insights, highlighting profitability gains, innovation, and strategic growth plans amidst China's demand challenges.

Philips shares took a hit today on fourth-quarter results that included potentially concerning performance in China.

The company said, ” Philips remains focused on successfully executing its three-year plan to drive operational improvements and crea ...

Philips on Wednesday posted worse-than-expected losses in 2024, as the Dutch medical device maker bids to turn the page on a ...

Full Year and Q4 Group performance highlightsSales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in ...

European markets opened in mixed territory Wednesday, with investors assessing more earnings releases and the latest U.K.

Nicko displays the device, a Philips DreamStation, to the camera, noting that it has “now been recalled.” He claims this is ...

Competing interests ME reports personal fees from Resmed, personal fees from Phillips Respironics, MIP reports personal fees from Philips Respironics, DEB reports personal fees from Nutricia, Baxter, ...